267 related articles for article (PubMed ID: 9324359)
1. T cell receptor recognition of MHC class II-bound peptide flanking residues enhances immunogenicity and results in altered TCR V region usage.
Carson RT; Vignali KM; Woodland DL; Vignali DA
Immunity; 1997 Sep; 7(3):387-99. PubMed ID: 9324359
[TBL] [Abstract][Full Text] [Related]
2. The majority of immunogenic epitopes generate CD4+ T cells that are dependent on MHC class II-bound peptide-flanking residues.
Arnold PY; La Gruta NL; Miller T; Vignali KM; Adams PS; Woodland DL; Vignali DA
J Immunol; 2002 Jul; 169(2):739-49. PubMed ID: 12097376
[TBL] [Abstract][Full Text] [Related]
3. Recognition of core and flanking amino acids of MHC class II-bound peptides by the T cell receptor.
Sant'Angelo DB; Robinson E; Janeway CA; Denzin LK
Eur J Immunol; 2002 Sep; 32(9):2510-20. PubMed ID: 12207335
[TBL] [Abstract][Full Text] [Related]
4. Naturally processed HLA class II peptides reveal highly conserved immunogenic flanking region sequence preferences that reflect antigen processing rather than peptide-MHC interactions.
Godkin AJ; Smith KJ; Willis A; Tejada-Simon MV; Zhang J; Elliott T; Hill AV
J Immunol; 2001 Jun; 166(11):6720-7. PubMed ID: 11359828
[TBL] [Abstract][Full Text] [Related]
5. Amino acid residues that flank core peptide epitopes and the extracellular domains of CD4 modulate differential signaling through the T cell receptor.
Vignali DA; Strominger JL
J Exp Med; 1994 Jun; 179(6):1945-56. PubMed ID: 7515103
[TBL] [Abstract][Full Text] [Related]
6. Co-dominant restriction by a mixed-haplotype I-A molecule (alpha k beta b) for the lysozyme peptide 52-61 in H-2k x H-2b F1 mice.
Moreno J; Adorini L; Hämmerling GJ
J Immunol; 1990 May; 144(9):3296-304. PubMed ID: 1970351
[TBL] [Abstract][Full Text] [Related]
7. Minute quantities of a single immunodominant foreign epitope are presented as large nested sets by major histocompatibility complex class II molecules.
Vignali DA; Urban RG; Chicz RM; Strominger JL
Eur J Immunol; 1993 Jul; 23(7):1602-7. PubMed ID: 7686856
[TBL] [Abstract][Full Text] [Related]
8. Comparison of structural requirements for interaction of the same peptide with I-Ek and I-Ed molecules in the activation of MHC class II-restricted T cells.
Leighton J; Sette A; Sidney J; Appella E; Ehrhardt C; Fuchs S; Adorini L
J Immunol; 1991 Jul; 147(1):198-204. PubMed ID: 1711074
[TBL] [Abstract][Full Text] [Related]
9. A peptide-binding motif for I-A(g7), the class II major histocompatibility complex (MHC) molecule of NOD and Biozzi AB/H mice.
Harrison LC; Honeyman MC; Trembleau S; Gregori S; Gallazzi F; Augstein P; Brusic V; Hammer J; Adorini L
J Exp Med; 1997 Mar; 185(6):1013-21. PubMed ID: 9091575
[TBL] [Abstract][Full Text] [Related]
10. Cross-reactive trinitrophenylated peptides as antigens for class II major histocompatibility complex-restricted T cells and inducers of contact sensitivity in mice. Limited T cell receptor repertoire.
Kohler J; Martin S; Pflugfelder U; Ruh H; Vollmer J; Weltzien HU
Eur J Immunol; 1995 Jan; 25(1):92-101. PubMed ID: 7843258
[TBL] [Abstract][Full Text] [Related]
11. T cell recognition of major histocompatibility complex class II complexes with invariant chain processing intermediates.
Morkowski S; Goldrath AW; Eastman S; Ramachandra L; Freed DC; Whiteley P; Rudensky AYu
J Exp Med; 1995 Nov; 182(5):1403-13. PubMed ID: 7595211
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms and consequences of peptide selection by the I-Ak class II molecule.
Latek RR; Unanue ER
Immunol Rev; 1999 Dec; 172():209-28. PubMed ID: 10631948
[TBL] [Abstract][Full Text] [Related]
13. T-cell receptor repertoires utilized in response to linear peptides representing an immunodominant MHC class II restricted T-cell epitope are far more diverse than that utilized in response to the same epitope in the nominal antigen.
Huang CC; Ts'ao PY; Manser T
Mol Immunol; 1998 Apr; 35(5):279-91. PubMed ID: 9747888
[TBL] [Abstract][Full Text] [Related]
14. Interaction of an immunodominant epitope with Ia molecules in T-cell activation.
Adorini L; Sette A; Buus S; Grey HM; Darsley M; Lehmann PV; Doria G; Nagy ZA; Appella E
Proc Natl Acad Sci U S A; 1988 Jul; 85(14):5181-5. PubMed ID: 2455895
[TBL] [Abstract][Full Text] [Related]
15. Functional mapping of MHC class II polymorphic residues. The alpha-chain controls the specificity for binding an Ad-versus an A k-restricted peptide and the beta-chain region 65-67 controls T cell recognition but not peptide binding.
Lee JM; McKean DJ; Watts TH
J Immunol; 1991 May; 146(9):2952-9. PubMed ID: 1849939
[TBL] [Abstract][Full Text] [Related]
16. Complexes generated by the binding of free peptides to class II MHC molecules are antigenically diverse compared with those generated by intracellular processing.
Viner NJ; Nelson CA; Deck B; Unanue ER
J Immunol; 1996 Apr; 156(7):2365-8. PubMed ID: 8786292
[TBL] [Abstract][Full Text] [Related]
17. Selective immunosuppression by administration of major histocompatibility complex (MHC) class II-binding peptides. I. Evidence for in vivo MHC blockade preventing T cell activation.
Guéry JC; Sette A; Leighton J; Dragomir A; Adorini L
J Exp Med; 1992 May; 175(5):1345-52. PubMed ID: 1569402
[TBL] [Abstract][Full Text] [Related]
18. Modification of the inhibitory amino acid for epitope peptide binding onto major histocompatibility complex class II molecules enhances immunogenicity of the antigen.
Chang SH; Kim J; Lee KY; Kim HJ; Chung YJ; Park CU; Kim BS; Jang YS
Scand J Immunol; 2004 Feb; 59(2):123-32. PubMed ID: 14871288
[TBL] [Abstract][Full Text] [Related]
19. Analysis of peptide binding patterns in different major histocompatibility complex/T cell receptor complexes using pigeon cytochrome c-specific T cell hybridomas. Evidence that a single peptide binds major histocompatibility complex in different conformations.
Bhayani H; Paterson Y
J Exp Med; 1989 Nov; 170(5):1609-25. PubMed ID: 2553848
[TBL] [Abstract][Full Text] [Related]
20. Structure-function relationship among T-cell receptors specific for lysozyme peptides bound to Ab or Abm-12 molecules.
Kobori JA; Hood L; Shastri N
Proc Natl Acad Sci U S A; 1992 Apr; 89(7):2940-4. PubMed ID: 1313573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
